Patent ID: 11897927
Assignee: ADVAXIS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 47:
48. The recombinant Listeria strain of claim 47, wherein:
(a) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 791-801;
(b) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 793, 794, and 799-806;
(c) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 791, 793, 796, 798-800, 812, and 815-819;
(d) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 791, 795, 797, 798, 801, and 807-815;
(e) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 791, 793, 796, 798-801, 810, 812, 815, and 816;
(f) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 820, 791, 793, 798, 815, 816, 799, 796, 801, 807-809, 803, and 800;
(g) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 791, 793, 796, 798-801, 803, 807-809, 815, 816, and 820;
(h) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 791, 792, 799-801, 803, 807-809, and 816;
(i) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 791-797, 799, 801, and 817; or
(j) the antigenic peptides comprise one or more or all of the peptides set forth in SEQ ID NOS: 791, 793, 794, 796, 798-800, 813, 815, and 816.